| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/20/2023 | 42.41% | Raymond James | $6 → $4.5 | Maintains | Outperform |
| 10/17/2023 | 116.77% | JP Morgan | $7.24 → $6.85 | Maintains | Overweight |
| 07/21/2023 | 86.71% | Goldman Sachs | $6.6 → $5.9 | Maintains | Buy |
| 07/17/2023 | 89.87% | Northland Capital Markets | $7 → $6 | Maintains | Outperform |
| 04/21/2023 | 89.87% | Raymond James | $7 → $6 | Maintains | Outperform |
| 01/27/2023 | 121.52% | Raymond James | $6.5 → $7 | Maintains | Outperform |
| 10/21/2022 | 105.7% | Raymond James | $7 → $6.5 | Maintains | Outperform |
| 10/13/2022 | — | Barclays | Initiates Coverage On | → Equal-Weight | |
| 09/26/2022 | — | Redburn Partners | Initiates Coverage On | → Buy | |
| 09/15/2022 | — | Credit Suisse | Upgrades | Neutral → Outperform | |
| 07/22/2022 | — | Kepler Cheuvreux | Downgrades | Buy → Hold | |
| 07/22/2022 | 121.52% | Raymond James | $6.75 → $7 | Maintains | Outperform |
| 04/29/2022 | 113.61% | Raymond James | $6.5 → $6.75 | Maintains | Outperform |
| 03/17/2022 | — | Jefferies | Initiates Coverage On | → Buy | |
| 03/14/2022 | 105.7% | Raymond James | → $6.5 | Upgrades | Market Perform → Outperform |
| 07/30/2021 | 153.16% | Cowen & Co. | $5 → $8 | Upgrades | Market Perform → Outperform |
| 07/14/2021 | 146.84% | JP Morgan | → $7.8 | Upgrades | Neutral → Overweight |
| 06/25/2021 | — | Goldman Sachs | Upgrades | Neutral → Buy | |
| 05/07/2021 | — | Morgan Stanley | Upgrades | Equal-Weight → Overweight | |
| 09/08/2020 | — | Raymond James | Downgrades | Strong Buy → Market Perform | |
| 07/08/2020 | — | JP Morgan | Downgrades | Overweight → Neutral | |
| 06/01/2020 | 74.05% | JP Morgan | $4.2 → $5.5 | Maintains | Overweight |
| 05/01/2020 | 58.23% | MKM Partners | $6 → $5 | Maintains | Buy |
| 03/02/2020 | 89.87% | Northland Capital Markets | → $6 | Initiates Coverage On | → Outperform |
| 01/07/2020 | — | New Street Research | Upgrades | Neutral → Buy | |
| 01/06/2020 | 42.41% | Raymond James | $5.5 → $4.5 | Upgrades | Outperform → Strong Buy |
| 10/25/2019 | 74.05% | MKM Partners | $7.5 → $5.5 | Maintains | Buy |
| 10/25/2019 | 32.91% | JP Morgan | $7.5 → $4.2 | Downgrades | Overweight → Neutral |
| 07/26/2019 | — | Charter Equity | Upgrades | Market Perform → Buy | |
| 04/15/2019 | — | Goldman Sachs | Downgrades | Neutral → Sell | |
| 01/08/2019 | 137.34% | Raymond James | → $7.5 | Upgrades | Market Perform → Outperform |
| 01/04/2019 | 137.34% | BMO Capital | $5 → $7.5 | Upgrades | Market Perform → Outperform |
| 10/26/2018 | — | Canaccord Genuity | Upgrades | Hold → Buy |
What is the target price for Nokia (NOK)?
The latest price target for Nokia (NYSE: NOK) was reported by Raymond James on October 20, 2023. The analyst firm set a price target for $4.50 expecting NOK to rise to within 12 months (a possible 42.41% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nokia (NOK)?
The latest analyst rating for Nokia (NYSE: NOK) was provided by Raymond James, and Nokia maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Nokia (NOK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nokia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nokia was filed on October 20, 2023 so you should expect the next rating to be made available sometime around October 20, 2024.
Is the Analyst Rating Nokia (NOK) correct?
While ratings are subjective and will change, the latest Nokia (NOK) rating was a maintained with a price target of $6.00 to $4.50. The current price Nokia (NOK) is trading at is $3.16, which is out of the analyst's predicted range.